论文部分内容阅读
使用中药介入治疗原发性肝癌１６例（莪术油治疗１２例，榄香烯治疗４例），其中５例为肝细胞肝癌，其余为临床诊断。临床分期，Ⅱ期１例，Ⅲ期１５例。同时服用辨证施治中药。治疗结果：肿瘤部分缓解（ＰＲ）５例，有效率为３１．２５％；瘤体缩小８例，瘤体缩小率为５０％；ＡＦＰ转阴４例，下降４例，占６１．５％（８／１３）；腹水征改善或消失３例，占４２．９％（３／７）；黄疸减轻或消退６例，占７５％（６／８）；肝功能ＧＰＴ恢复正常３例，改善２例，占５０％（５／１０）。疗后生存期：半年生存率为８３．３％（１０／１２），１年生存率为６０％（６／１０）。说明中药介入治疗晚期原发性肝癌有较好疗效。
There were 16 cases of primary liver cancer treated with traditional Chinese medicine interventional therapy (12 cases of Curcuma oil treatment and 4 cases of Elemene), of which 5 cases were hepatocellular carcinoma and the rest were clinical diagnosis. Clinical stage was 1 case in stage II and 15 cases in stage III. At the same time take the syndrome differentiation of traditional Chinese medicine. Therapeutic results: 5 cases of partial tumor remission (PR), the effective rate was 31.25%; 8 cases of tumor shrinkage, tumor shrinkage was 50%; AFP negative 4 cases, 4 cases decreased, accounting for 61.5% ( 8/13); Ascites syndrome improved or disappeared in 3 cases, accounting for 42.9% (3/7); jaundice reduced or subsided in 6 cases, accounting for 75% (6/8); liver function GPT returned to normal in 3 cases, improvement 2 Example, accounting for 50% (5/10). Survival after treatment: The six-year survival rate was 83.3% (10/12), and the 1-year survival rate was 60% (6/10). It shows that traditional Chinese medicine interventional treatment of advanced primary liver cancer has a good effect.